Drug
Tedizolid
Tedizolid: highest development phase Phase 3, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tedizolid phosphate NCT03176134 | Phase 3 | Acute Bacterial Skin and Skin Structure Infections |
Latest
No recent events.
Follow Tedizolid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.